Hydrochloric Acid

Hydrochloric Acid

SCHEMBL252608

C=C(C)C(=O)OC.C=C(C)C(=O)OCC[N+](C)(C)C.[Cl-]

nearest known ligand 0.57

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ACHEBDKRB2CHRM1CHRM2CHRM3CHRNA1CHRNB1CHRNDCHRNECHRNGGUCY1A1GUCY1A2GUCY1B1GUCY1B2NAMPTPTAFRSLC10A2SLC6A2SLC6A3TACR1dacAdacBdacCftsImrcAmrcBmrdA

The experimentally established mechanism targets of Hydrochloric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CHRM1 known ✓ P11229 6/20 0.57
CHRM3 known ✓ P20309 6/20 0.57
CHRM2 known ✓ P08172 5/20 0.53
ACHE known ✓ P22303 1/20 0.40
CHRM5 P08912 6/20 0.57
ALDH1A1 P00352 1/20 0.56
CHRM4 P08173 5/20 0.53
CHRNB2 P17787 4/20 0.53
CHRNA4 P43681 4/20 0.53
CHRNA7 P36544 3/20 0.53
SMN1; SMN2 Q16637 2/20 0.53
HTR1A P08908 2/20 0.53
PGR P06401 1/20 0.53
TBXA2R P21731 1/20 0.53
CHRNB4 P30926 1/20 0.53
CHRNA3 P32297 1/20 0.53
CHRNA10 Q9GZZ6 1/20 0.53
CHRNA9 Q9UGM1 1/20 0.53
GALR3 O60755 2/20 0.52
MAPT P10636 1/20 0.52

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL180003 0.92 CHRM5 (0.65) CHRM5CHRM1CHRM3CHRM2CHRM4
Hydrochloric Acid SCHEMBL15954 0.92 CHRM5 (0.65) CHRM5CHRM1CHRM3CHRM2CHRM4
Hydrochloric Acid SCHEMBL30183040 0.92 CHRM5 (0.65) CHRM5CHRM1CHRM3CHRM2CHRM4
Hydrochloric Acid SCHEMBL28569529 0.91 TSHR (0.58) CHRM5CHRM1CHRM3ALDH1A1CHRM2
Hydrochloric Acid SCHEMBL9492830 0.90 CHRM5 (0.63) CHRM5CHRM1CHRM3CHRM2CHRM4
Iodide SCHEMBL723953 0.90 CHRM5 (0.63) CHRM5CHRM1CHRM3CHRM2CHRM4
Bromide SCHEMBL366432 0.90 CHRM1 (0.63) CHRM5CHRM1CHRM3CHRM2CHRM4
Ammonia Solution, Strong SCHEMBL468696 0.90 CHRM5 (0.63) CHRM5CHRM1CHRM3CHRM2CHRM4
SCHEMBL31575073 0.90 CHRM5 (0.63) CHRM5CHRM1CHRM3CHRM2CHRM4
SCHEMBL29649178 0.90 CHRM5 (0.63) CHRM5CHRM1CHRM3CHRM2CHRM4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 34 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11826470-B2 Preparation of solid dosage forms comprising antibodies by solution/suspension layering TILLOTTS PHARMA AG (CH) 2023-11-28 US claimed
CN-113150622-A Photocatalyst coating with heat preservation performance and preparation method thereof 董峰 2021-07-23 CN claimed
CN-113072390-A Porous ceramic heating body and preparation method thereof 上海梦泺企业管理咨询有限公司 2021-07-06 CN claimed
CN-110343441-B Water-based negative ion coating and preparation method thereof 炫杰复合材料(上海)有限公司 2021-03-26 CN claimed
US-10293046-B2 Compositions and methods for reducing overdose INTELLIPHARMACEUTICS CORP. (CA) 2019-05-21 US claimed
US-8465777-B2 Diffusion-controlled dosage form and method of fabrication including three dimensional printing THE MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) 2013-06-18 US claimed
US-20120177696-A1 Diffusion-controlled dosage form and method of fabrication including three dimensional printing THE MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) 2012-07-12 US claimed
US-8088415-B2 Core-and-shell dosage form or unit in which the core contains API and in which the shell substantially governs the release such as by controlling diffusion of API through the shell. The shell may comprise a release-blocking polymer, and particles THE MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) 2012-01-03 US claimed
EP-1421932-B1 Polyacrylic film forming compositions MCNEIL PPC INC (US) 2010-09-22 EP claimed
EP-1503741-B1 DIFFUSION-CONTROLLED DOSAGE FORM AND METHOD OF FABRICATION INCLUDING THREE DIMENSIONAL PRINTING MASSACHUSETTS INST TECHNOLOGY (US) 2008-09-10 EP claimed
EP-1503741-A2 DIFFUSION-CONTROLLED DOSAGE FORM AND METHOD OF FABRICATION INCLUDING THREE DIMENSIONAL PRINTING MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) 2005-02-09 EP claimed
EP-1421932-A1 Polyacrylic film forming compositions McNEIL-PPC, INC. (US) 2004-05-26 EP claimed
US-20040022755-A1 Polyacrylic film forming compositions JOHNSON & JOHNSON CONSUMER INC. 2004-02-05 US claimed
US-20040005360-A1 Diffusion-controlled dosage form and method of fabrication including three dimensional printing THERICS, INC. 2004-01-08 US claimed
WO-2003092633-A2 DIFFUSION-CONTROLLED DOSAGE FORM AND METHOD OF FABRICATION INCLUDING THREE DIMENSIONAL PRINTING MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) 2003-11-13 WO claimed
US-6156340-A Orally administrable time release drug containing products DUQUESNE UNIVERSITY OF THE HOLY GHOST (US) 2000-12-05 US claimed
CN-115464135-B Injection molding feed with modified stainless steel powder and cationic binder 合肥工业大学 2023-06-23 CN disclosed
CN-115464135-A Injection molding feed with modified stainless steel powder and cationic binder 合肥工业大学 2022-12-13 CN disclosed
US-6156340-A Orally administrable time release drug containing products DUQUESNE UNIVERSITY OF THE HOLY GHOST (US) 2000-12-05 US disclosed
US-4439322-A IONIC COPOLYMER TORAY INDUSTRIES, INC. (JP) 1984-03-27 US disclosed